Slaughter R L, Schneider P J, Visconti J A
Am J Hosp Pharm. 1978 Nov;35(11):1376-9.
The use of 145 digoxin and digitoxin assays was studied in a teaching hospital to determine if performance of assays was appropriate and therapeutically beneficial. Patient charts (121) were randomly selected from a list of all patients for whom digoxin or digitoxin assays were performed. Charts were compared with established criteria to determine whether the assay was indicated and performed correctly and whether dosage was adjusted correctly based on assay results. Of the assays reviewed, 49% were performed for irrational indications; 86% were performed appropriately under steady-state conditions; and 96% used serum samples appropriately drawn more than six hours after administration of the last digitalis glycoside dose. Of the assays performed at appropriate times in relation to dose and at steady-state plasma concentrations (120), 31 should have and 89 should not have resulted in a dosage change. Of the latter, 98% were evaluated correctly. Of the former, 36% were not evaluated correctly (i.e., indicated dosage adjustments were not made). Control of the use of digitalis glycoside assays is needed. Pharmacists should become involved in monitoring drug assays to assure appropriateness of assay request, interpretation and follow-up.
在一家教学医院对145次地高辛和洋地黄毒苷检测的使用情况进行了研究,以确定检测的执行是否恰当以及在治疗上是否有益。从所有进行了地高辛或洋地黄毒苷检测的患者名单中随机选取了121份患者病历。将病历与既定标准进行比较,以确定检测是否有必要、执行是否正确,以及是否根据检测结果正确调整了剂量。在所审查的检测中,49%的检测是出于不合理的指征进行的;86%的检测在稳态条件下进行得恰当;96%的检测使用了在最后一剂洋地黄糖苷给药后六小时以上适当采集的血清样本。在与剂量相关的适当时间且在稳态血浆浓度下进行的检测(120次)中,31次检测应该导致且89次检测不应该导致剂量改变。在后者中,98%的检测评估正确。在前者中,36%的检测评估不正确(即未进行指示的剂量调整)。需要对地高辛检测的使用进行控制。药剂师应参与监测药物检测,以确保检测申请、解读和后续跟进的恰当性。